NationalStockNumber.INFO
Worldwide distributor of NSN parts and consumables located in the USA.
Worldwide distributor of NSN parts and consumables located in the USA.
| Solicitation | Return by Date | Buyer Code | Quantity |
|---|---|---|---|
| SPE2DP20Q0248 | 2020-04-09 | DHM00 | 1 VI |
Send us a request for quote using the form below. Our team will contact you with an up to date pricing and availability quote ASAP.
Anticonvulsants, hypnotics and sedatives, primarily affecting central nervous system, put up in measured doses or in forms or packings for retail sal
Medicaments, n.E.S., in dosage form or retail packings
Pharmaceutical preparations
Y - Indicates information is in the hazardous materials information resource system (hmirs).
PMICA - Item does not contain precious metal.
CRITL- The item does not have a nuclear hardened feature or any other critical feature such as tolerance, fit restriction or application.
058770 - Drugs/medicines/vitamins noi
532 - Drugs and medicines excluding pencillin, sulfa, serums, vaccines, and vitamins (not requiring temperature control)
9 - Other or no special handling required (sh)
A - Shipment is not a consolidation and does not exceed 84 inches in any dimension.
M - Medical supplies, equipment, samples, records, etc.
Q - Subject to damage from freezing
W - Rating variable
Questions & Answers: |
|
| What are the historical prices recorded for this stock number? | |
| Historical data shows pricing from $11.26 to $18.77.. | |
| Does NSN 6505-00-138-7347 have a shelf life? | |
| No. There is no shelf life applicable for this NSN. | |
| What NATO entities are users of this NSN? | |
| Department Of The Army, Department Of The Air Force, Department Of The Navy, Veterans Administration, and Kuwait | |
| What is the NIIN of NSN 6505-00-138-7347? | |
| 001387347 or 00-138-7347 | |
| Does NSN 6505-00-138-7347 require demilitarization? | |
| Yes - ITAR Controlled | |
| What is the most recent solicitation for NSN 6505-00-138-7347? | |
| Solicitation SPE2DP20Q0248 for qty 1 on 04/03/2020 | |
| When was this national stock number assigned to the federal catalog? | |
| Oct 27, 1974 | |
Ld50 lc50 mixture: ld50 (scu, rat) is 48 mg/kg.
routes of entry: inhalation: yes skin: yes ingestion: yes
reports of carcinogenicity: ntp: no iarc: no osha: no
health hazards acute and chronic: the hazardous highly toxic product
concentration in 50 ml vials is either 0.25% or 0.50%. Therefore,
vials are not considered hazardous. Also, no hazard for intact
vials. The concentrated drug produce s numbness by blocking nerve
conduction.This action may adversely affect the cns and heart.
explanation of carcinogenicity: there are no ingredients above 0.1%
which are identified as carcinogens by ntp,iarc or osha.
effects of overexposure: systemic toxicity: numbness,
excitation/depression, restlessness, anxiety, dizziness, blurred
vision, tremors, convulsions, hypotension, slowed pulse, heart
arrythmia, "ringing ears".
medical cond aggravated by exposure: persons with pre-existing cns or
heart ailments or sensitivity to amide type local anesthetics may
be at increased risk from exposure.
First aid: if toxicity symptoms occur, get medical assistance. Eyes:
flush with water for 15 minutes. Inhalation: move to fresh air.
give oxygen or artificial respiration if needed. Ingestion: do not
induce vomi ting. Get prompt qualified medical attention. No
antidote; treat symptomatically and supportively.
Hcc: n1
boiling pt: b.P. Text: 212f,100c
melt/freeze pt: m.P/f.P text: 32.0f,0.0c
spec gravity: 1
ph: 4-6.5
solubility in water: complete
appearance and odor: liquid;clear.Odor not reported.
percent volatiles by volume: neglig
Stability indicator/materials to avoid: yes
none specified by manufacturer.
stability condition to avoid: none specified by manufacturer.
hazardous decomposition products: none specified by manufacturer.
Waste disposal methods: dispose of in accordance with federal,state and
local regulations.
disclaimer (provided with this information by the compiling agencies):
this information is formulated for use by elements of the department
of defense. the united states of america in no manner whatsoever,
expressly or implied, warrants this information to be accurate and
disclaims all liability for its use. any person utilizing this
document should seek competent professional advice to verify and
assume responsibility for the suitability of this information to their
particular situation.
Ingred name: bupivacaine hydrochloride
cas: 18910-40-7
fraction by wt: .25-.5%
other rec limits: none recommended